Category Archives: Investment Research

Sahm Adrangi Of Kerrisdale Capital Tries To Expose Kodaks Exploits

Published / by Logan / Leave a Comment

Sahm Adrangi has stated clearly that he is unimpressed with the latest efforts being made at Eastman Kodak, which is a printing and photo company that has been in operation for quite a long time, and at one time was the biggest contender in the market. Sahm Adrangi of Kerrisdale Capital has recently called out Kodak for their questionable stock price changes, reaching almost a 200 percent increase. This turns out to be hundreds of millions of dollars in profit in a just small amount of time. Kerrisdale has been observing the activity of Kodak and the large share values obtained by the Kodak board representatives. All of this happened right after Kodak made the announcement of its involvement in cryptocurrency.

Kerrisdale has reported that Kodak and a cryptocurrency group were partnering up in order to sort out a few copyright violation issues. Unfortunately for Kodak, this new move might not help them at all with their current problems. Hardly any publicity has been generated under Kodak’s new allegiance with a cryptocurrency group, which will ultimately cause Kodak’s revival to fail. Sahm Adrangi also warns people to be wary of not only Kodak, but Kodak’s partner’s as well. These crypto groups have been found to be unreliable, especially with the volatile crypto market that is currently in place. On an even worse note, Kerrisdale has plainly stated that KodakOne is a total scam business and is a last-ditch effort to gain their assets back.

Kerrisdale was started up back in 2009 by Sahm Adrangi, and he currently resides as the company’s CEO. Sahm has unique principles in place at Kerrisdale and takes communication very seriously when it comes to making investments. Much of the experience Sahm gained to started off his investing career came from Yale University, where Sahm studied Economics. After graduating and finding his way into the industry, Sahm ended up working with several prestigious investment firms, including Longacre Fund Management, Deutsche Bank, and even Chanin Capital Partners. Sahm is dedicated to pushing out the shady business practices and suspicious moves made by company’s these days. This is why Kerrisdale continues to issues reports on various companies and their actions as a way to alert all investors out there.

https://www.kerrisdalecap.com/firm/sahm-adrangi/

Learn about Investor Shervin Pishevar

Published / by Logan / Leave a Comment

Shervin Pishevar is an angel investor, venture capitalist, published researcher, multiple entrepreneurs, incubation expert, and start-up advisor. Today, Shervin is the Cofounder of two successful ventures, which are Hyperloop Technologies and Sherpa Capital. Sherpa Ventures is a capital firm based in Francisco, and Shervin also works there as the Managing director.

From the love of innovation and technology, Shervin Pishevar has founded several technological- related companies since his early years in the career, explaining his love for technology entrepreneurship. Between 1997 and 2001 Shervin was the CEO of WebOS, which he has founded. He also cofounded Seges Capital and Application Corporation in 2001. From 2001 to 2004, Shervin Pishevar served as the President, Head of Products, Sales, and business development, as well as the Cofounder of Inside Interactive. Shervin also worked with Webs, Inc. as the company’s COO and Founding president between 2005 to 2011.

Shervin Pishevar joined Menlo Ventures in 2011, as the Venture Advisor and managing director. He was really helpful in the Menlo Talent Fund launch, which happened in 2011. The seed fund was worth $20 million. In his position in Menlo, Shervin was able to work closely with teams from Machine Zone, Uber, Warby Parker, Tumblr, and Fab. He had under his management over $4 billion.

Over the years Shervin Pishevar has made a lot of investments to more than 60 companies in different sectors.

Shervin is a member of the Global Entrepreneur Council in the UN Foundation. He is also in the Comscore’s Advisory board. In 2012, Shervin was honored as an “Outstanding American by Choice.” BY Homeland Security Department in 2008. In many state department delegations, Shervin has been appointed Entrepreneurial Ambassador to Russia and the Middle East. In the Obama’s Entrepreneurial Summit in Algeria in 2008, Shervin was the keynote speaker. He also assisted in the creation of the Technology and Innovation plan, by being part of the policy working group. Go Here for related Information.

Shervin Pishevar is an alumnus of University of California, Berkley, where he acquired a bachelors degree in Arts. He is the author of numerous U.S. patents while his research has been published in Neuroscience Letters and JAMA. Since 2015, Shervin has been serving in the board of J. William Fulbright Foreign Scholarship.

Related Article: https://genius.com/artists/Shervin-pishevar

How Sahm Adrangi Made Money For His Hedge Fund Betting Against Three Biotech Companies

Published / by Logan / Leave a Comment

Kerrisdale Capital Management LLC is a New York, New York investment management company founded by its chief investment officer, Sahm Adrangi. When he founded this company in 2009 he had been in the financial industry for five years, working as an analyst for three different firms. During this time he had developed extensive experience in financial matters such as leveraged financing, bankruptcy restructuring, and distressed debt.

 

When Sahm Adrangi started Kerrisdale it had been with money that he had saved coupled with money his parents wanted him to manage as well as other supporters. He started out with $1 million and by July 2017 he had developed this into $150 million in assets under management. He has built up a team of analysts that carry out research that he then uses to make his investment decisions.

 

Starting in the second half of 2017, Sahm Adrangi started to target businesses in the biotech industry that his research showed were not the great investments that others thought they were. One of these was Bavarian Nordic which was developing a cancer drug. Adrangi had said that their cancer vaccine was a big failure. Once its study on this vaccine was complete it was proven that Sahm had been right. He had shorted this company’s stock which led to a profit windfall for his hedge fund.

 

Another biotech company that Sahm Adrangi has shorted in last few months is Prothena. Their market cap had exceeded $2 billion on hopes for its AL amyloidosis drug. The analysts working for Kerrisdale said that their research showed this drug had zero promise. Their Phase IIb and Phase III studies on this drug have yet to be completed but he is completely sure that this drug has absolutely no value and expects Prothena’s stock to plummet. Get More Information Here.

 

Sahm Adrangi had also been proven right about another drug manufacturer in 2017, Sage. He shorted their stock and was proven to have been right to do so not long after. As it turns out the drug that they were developing had turned out to be as ineffective as a placebo.

 

Visit: http://www.zerohedge.com/news/2017-05-09/kerrisdale-capital-reveals-latest-short-selling-target-will-it-be-next-straight-path